Beren Therapeutics P.B.C.®, the parent company of Mandos LLC® and a leader in cholesterol trafficking biology and ...
The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...
OSAKA, Japan & CAMBRIDGE, Mass. & HONG KONG & SHANGHAI & FLORHAM PARK, N.J.--(BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM:HCM ...
NDA Includes 52-Week Data from Phase 3 VERIFY Study, Which Met the Primary and All Four Key Secondary Endpoints, Showing Rusfertide Provided Durable and Sustained Hematocrit Control and Improved ...
MIAMI--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) ...
10don MSN
NDA 2 Application Form 2026 Releasing Tomorrow, Check Steps to Apply, Required Documents Here
UPSC NDA 2 Application Form 2026: Candidates who wish to appear for the NDA exam must complete the online registration process before June 9, 2026.
UPSC NDA Exam 2026 Notification: The Union Public Service Commission (UPSC) is scheduled to release the NDA II 2026 notification today, May 20, 2026. Candidates can apply online at upsconline.nic.in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results